Physician profile
Arron Wright
NPI 1568177988
$2,175.79
in general payments reported to CMS, 2019-2025
14 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what 89% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $583 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $586.05 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $291.11 | 2025 | Caplyta |
| Abbvie INC. | $260.91 | 2025 | |
| Ironshore Pharmaceuticals INC. | $253.92 | 2024 | |
| Alkermes, INC. | $165.26 | 2024-2025 | Lybalvi |
| Supernus Pharmaceuticals, INC. | $146.45 | 2025 | Qelbree |
| Biogen, INC. | $105.89 | 2025 | Zurzuvae |
| Janssen Pharmaceuticals, INC | $85.18 | 2024-2025 | Spravato, Invega |
| Lundbeck LLC | $73.51 | 2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $69.71 | 2024-2025 | Trintellix |
| Corium, LLC | $50.76 | 2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $35.39 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $35.17 | 2024-2025 | Relexxii |
| Neos Therapeutics, Lp | $16.48 | 2025 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arron Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.